Arteris (AIP) CEO Janac logs 203,588-share sale, keeps 8.9M+ stake
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Arteris, Inc. director, President and CEO K. Charles Janac reported multiple sales of Arteris common stock on July 2, 2026. The Form 4 shows net sales of 203,588 shares at various weighted average prices between $34.20 and $43.51 per share.
According to the footnotes, a portion of the shares was sold to satisfy Mr. Janac’s tax liability from the release of restricted stock units under the company’s equity incentive plans, using mandatory “sell to cover” transactions rather than discretionary trades. Additional sales were made by Bayview Legacy, LLC under a pre-arranged Rule 10b5-1 trading plan adopted on December 12, 2025.
After these transactions, Mr. Janac continues to hold Arteris shares both directly and indirectly, including 56,252 shares held by the Charles and Lydia Janac Trust, 193,508 shares held directly, and 8,736,733 shares beneficially owned through Bayview Legacy, LLC.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 203,588 shares ($7,421,411)
Net Sell
13 txns
Insider
JANAC K CHARLES
Role
President and CEO
Sold
203,588 shs ($7.42M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,221 | $38.7779 | $125K |
| Sale | Common Stock | 2,293 | $38.7779 | $89K |
| Sale | Common Stock | 2,613 | $38.7779 | $101K |
| Sale | Common Stock | 2,775 | $38.7779 | $108K |
| Sale | Common Stock | 11,000 | $37.6074 | $414K |
| Sale | Common Stock | 39,880 | $36.6961 | $1.46M |
| Sale | Common Stock | 26,348 | $35.6723 | $940K |
| Sale | Common Stock | 80,042 | $34.7706 | $2.78M |
| Sale | Common Stock | 24,691 | $38.8891 | $960K |
| Sale | Common Stock | 5,482 | $39.7237 | $218K |
| Sale | Common Stock | 2,500 | $40.7832 | $102K |
| Sale | Common Stock | 2,743 | $43.2358 | $119K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 193,508 shares (Direct, null);
Common Stock — 8,736,733 shares (Indirect, Bayview Legacy)
Footnotes (1)
- Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.44 to $40.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.57 to $43.51 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.20 to $38.17 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.20 to $37.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.20 to $35.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.27 to $39.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.30 to $40.29 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Net shares sold: 203,588 shares
Direct holdings after transaction: 193,508 shares
Bayview Legacy holdings after sales: 8,736,733 shares
+3 more
6 metrics
Net shares sold
203,588 shares
Net sell activity on July 2, 2026
Direct holdings after transaction
193,508 shares
Common stock held directly after sales
Bayview Legacy holdings after sales
8,736,733 shares
Indirect beneficial ownership via Bayview Legacy, LLC
Trust holdings
56,252 shares
Common stock held by Charles and Lydia Janac Trust
Highest reported sale price
$43.51 per share
Upper end of stated weighted-average ranges
Lowest reported sale price
$34.20 per share
Lower end of stated weighted-average ranges
Key Terms
restricted stock units, sell to cover, Rule 10b5-1 trading plan, weighted average sale price, +1 more
5 terms
restricted stock units financial
"tax liability arising as a result of the release of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
Rule 10b5-1 trading plan financial
"Transaction made pursuant to a 10b5-1 trading plan that was adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
equity incentive plans financial
"mandated by the Issuer's election under its equity incentive plans"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
FAQ
What did Arteris (AIP) CEO K. Charles Janac report in this Form 4?
K. Charles Janac reported net sales of 203,588 Arteris common shares on July 2, 2026. The filing shows both direct and indirect holdings, including shares in a family trust and Bayview Legacy, LLC, with substantial ownership remaining after the transactions.
What role did a Rule 10b5-1 trading plan play in the Arteris (AIP) insider sales?
The filing states that certain sales by Bayview Legacy, LLC were executed under a Rule 10b5-1 trading plan. This plan was adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on December 12, 2025, indicating these transactions were pre-arranged rather than timed discretionarily.
At what prices were the reported Arteris (AIP) insider sales executed?
The reported sales occurred at various weighted average prices. Footnotes describe transaction price ranges from $34.20 to $43.51 per share, with shares sold in multiple trades within these ranges, rather than at a single uniform price for each transaction.